The incidence of diabetes mellitus in Russia in the trend over 2015–2024

Introduction. In recent years, there has been a marked increase in the incidence of diabetes mellitus (DM) in Russia, which places a heavy burden on the healthcare system.

The purpose: to consider the incidence of DM, including type 1 and type 2, as well as the contribution of active detection methods to the formation of its structure in Russia in the trend over the period from 2015 to 2024.

Materials and methods. Statistical data from form No. 12 and Rosstat on the population for 2015–2024. To analyze the incidence rates of diabetes, including type 1 and type 2, in the trend 2015–2024, dynamic range indicators and the Fisher criterion were used, the differences were significant at < 0.05.

Results. In Russia, the incidence of DM and diabetes type 2 increased markedly in 2015–2024 and reached 310.7 and 292.6 per 100,000 population in 2024. In the structure of the incidence of diabetes, the proportion of diabetes type 2 reached 92.2, and diabetes type 1 — 6.1%. In the structure of newly diagnosed patients with diabetes in 2024, the proportion of patients who were actively identified increased to 31.7% due to an increase in the proportion of patients identified during medical examinations to 27.6%.

Research limitations. Statistical information provides a sufficient sample for the study.

Conclusion. Currently, to analyze the incidence of diabetes in the Russian population, there is a need to develop a new federal statistical observation reporting form containing detailed information on newly diagnosed patients with diabetes.

Compliance with ethical standards. The conclusion of the biomedical ethics committee was not required for this study (the study was based on publicly available official statistics).

Contribution of the authors:
Starodubov V.I. — research concept;
Tsybikova E.B. — research design, text writing, bibliography;
Samoilova Yu.G. — concept and editing;
Kotlovskiy M.Yu. — collection and processing of material.
All co-authors are responsible for approving the final version of the article and ensuring the integrity of all parts of the article.

Funding. The research was not granted any sponsor support.

Conflict of interest. The authors declare no competing interests.

Received: July 7, 2025 / Revised: October 13, 2025 / Accepted: February 19, 2026 / Published: April 30, 2026

1. WHO. Diabetes; 2024. Available at: https://who.int/news-room/fact-sheets/detail/diabetes

2. de Boer I.H., Khunti K., Sadusky T., Tuttle K.R., Neumiller J.J., Rhee C.M., et al. Diabetes management in chronic kidney disease: a consensus report by the American Diabetes Association (ADA) and Kidney Disease: Improving Global Outcomes (KDIGO). Kidney Int. 2022; 102(5): 974–89. https://doi.org/10.1016/j.kint.2022.08.012

3. Kirkman M.S., Briscoe V.J., Clark N., Florez H., Haas L.B., Halter J.B., et al. Diabetes in older adults: a consensus report. J. Am. Geriatr. Soc. 2012; 60(12): 2342–56. https://doi.org/10.1111/jgs.12035

4. International Diabetes Federation. IDF Diabetes Atlas, 10th edition. Brussels; 2021. Available at: https://diabetesatlas.org/atlas/tenth-edition/

5. Gregory G.A., Robinson T.I.G., Linklater S.E., Wang F., Colagiuri S., de Beaufort C., et al. Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study. Lancet Diabetes Endocrinol. 2022; 10(10): 741–60. https://doi.org/10.1016/S2213-8587(22)00218-2

6. Diabetic retinopathy screening: a short guide. Copenhagen; 2020. Available at: https://iris.who.int/server/api/core/bitstreams/711e677f-c3d6-4eea-a188-6c772a60fa7c/content

7. Ogle G.D., James S., Dabelea D., Pihoker C., Svennson J., Maniam J., et al. Global estimates of incidence of type 1 diabetes in children and adolescents: Results from the International Diabetes Federation Atlas, 10th edition. Diabetes Res. Clin. Pract. 2022; 183: 109083. https://doi.org/10.1016/j.diabres.2021.109083

8. WHO list of priority medical devices for management of cardiovascular diseases and diabetes. WHO; 2021. Available at: https://who.int/publications/i/item/9789240027978

9. Chan J.C.N., Lim L.L., Wareham N.J., Shaw J.E., Orchard T.J., Zhang P., et al. The Lancet Commission on diabetes: using data to transform diabetes care and patient lives. Lancet. 2021; 396(10267): 2019–082. https://doi.org/10.1016/S0140-6736(20)32374-6

10. Dedov I.I., Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.A., Sazonova D.V., et al. Diabetes mellitus in the Russian Federation: dynamics of epidemiological indicators according to the federal register of diabetes mellitus for the period 2010-2022. Sakharnyi diabet. 2023; 26(2): 104–23. https://doi.org/10.14341/DM13035 https://elibrary.ru/dvdjwj (in Russian)

11. Dedov I.I., Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Isakov M.A., Kutakova D.V., et al. Epidemiology and key clinical and therapeutic indicators of diabetes mellitus in Russian Federation according to the world health organization’s strategy goals. Sakharnyi diabet. 2025; 28(1): 4–17. https://doi.org/10.14341/DM13292 https://elibrary.ru/uqhmtc (in Russian)

12. Dedov I.I., Shestakova M.V., Mayorov A.Y.u, Shamkhalova M.S., Sukhareva O.Yu., Galstyan G.R., et al. Diabetes mellitus type 2 in adults. Sakharnyi diabet. 2020; 23(2S): 4–102. https://doi.org/10.14341/DM12507 https://elibrary.ru/ybrimy (in Russian)

13. Dedov I.I., Shestakova M.V., Mayorov A.Yu., Mokrysheva N.G., Andreeva E.N., Bezlepkina O.B., et al. Standards of Specialized Diabetes Care. Edited by Dedov I.I., Shestakova M.V., Mayorov A.Yu. 11th edition. Sakharnyi diabet. 2023; 26(2S): 1–157. https://doi.org/10.14341/DM13042 https://elibrary.ru/dcklci (in Russian)

14. Tsybikova E.B., Kotlovskiy M.Yu. Diabetes mellitus incidence in moscow in 2013–2022. Sotsial’nye aspekty zdorov’ya naseleniya. 2024; 70(2): 19. https://doi.org/10.21045/2071-5021-2024-70-2-19 https://elibrary.ru/uxsmxo (in Russian)

15. NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants. Lancet. 2024; 404(10467): 2077–93. https://doi.org/10.1016/s0140-6736(24)02317-1

16. WHO. Tackling diabetes through meaningful engagement – Slovenia’s second 10-year programme; 2023. Available at: https://who.int/europe/news/item/27-11-2023-tackling-diabetes-through-meaningful-engagement–-slovenia-s-second-10-year-programme

17. Kyrgyzstan – analysis of diabetes data as a basis for improving the quality of medical care. Examples of solutions to the problem of NCDs in the country. – WHO Regional Office for Europe. Copenhagen, 2021. Available at: https://iris.who.int/bitstream/handle/10665/349951/WHO-EURO-2021-4146-43905-61957-rus.pdf (in Russian)

18. Dedov I.I., Shestakova M.V., Galstyan G.R. The prevalence of type 2 diabetes mellitus in the adult population of Russia (nation study). Sakharnyi diabet. 2016; 19(2): 104–12. https://doi.org/10.14341/DM2004116-17 https://elibrary.ru/wbaqhx (in Russian)

19. Shcherbakova E.M. The population of Russia in the future until 2045. Demoskop Weekly. 2024; (1015-1016): 1–20. https://elibrary.ru/dufxfp (in Russian)

20. Shestakova M.V., Vikulova O.K., Zheleznyakova A.V., Kutakova D.V., Isakov M.A., Mokrysheva N.G. Diabetes mellitus in the elderly: clinical and epidemiological characteristics of the all-Russian cohort of diabetic patients over 65 years. Sakharnyi diabet. 2024; 27(6): 504–19. https://doi.org/10.14341/DM13261 https://elibrary.ru/lcamjw (in Russian)